Dernières publications
Endothelial progenitor cells carrying monocyte markers are selectively abnormal in type 1 diabetic patients with early retinopathy
https://www.ncbi.nlm.nih.gov/pubmed/22338095
Gianpaolo Zerbini, Anna Maestroni, Alessio Palini, Gemma Tremolada, Rosangela Lattanzio, Silvia Maestroni, Matteo Rocco Pastore, Antonio Secchi, Riccardo Bonfanti, Chiara Gerhardinger, Mara Lorenzi
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
Diabetologia. May; 49(5):881-90, 2006
P. J. Bingley . E. A. M. Gale . The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group
Lire la suite
Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy
Diabetologia. May;49(5):1109-11, 2006.
Asnaghi V, Lattanzio R, Mazzolari G, Pastore MR, Ramoni A, Maestroni A, Ruggeri D, Luzi L, Brancato R, Zerbini G
Lire la suite
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
Diabetologia, May;49(5):881-90, 2006.
P. J. Bingley . E. A. M. Gale . The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group
Lire la suite
Lactulose and mannitol intestinal permeability detected by capillary electrophoresis
J Chromatogr B Analyt Technol Biomed Life Sci. Apr 13;834(1-2):183-7, 2006
Paroni R, Fermo I, Molteni L, Folini L, Pastore MR, Mosca A, Bosi E.
Lire la suite
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes
Lancet 363(9413):925-34, 2004
Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.
Lire la suite
Six months of gluten-free diet do not change islet autoantibodies, but improve insulin secretion in subjects at high risk for type 1 diabetes
J Clin Endocrinol Metab 88: 162-165, 2003.
Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E.
Lire la suite
Update on Worldwide Efforts to Prevent Type 1 Diabetes
Ann N Y Acad Sci 2008;1150:190-196. PMID 19120293, NIHMS225042
Skyler JS and the Type 1 Diabetes TrialNet Study Group
Lire la suite
Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
Diabetes Care 2008;31:1966-1971. PMID 18628574, PMC2251636
Greenbaum CJ, Mandrup-Poulsen T, Friedenberg-McGee P, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H, and The Type 1 Diabetes TrialNet Research Group and The European C-peptide Trial Study Group
Lire la suite
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.
Pediatric Diabetes 2009;10:97-104. PMID 18823409
Mahon J, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J, Skyler JS, for the TrialNet Natural History Committee and Type 1 Diabetes TrialNet Study Group.
Lire la suite
The Validation of the Diabetes Prevention Trial-Type 1 Risk Score and the detection of Pre-Diabetes in the TrialNet Natural History Study
Diabetes Care 2011;34:1785-1787. PMID: 21680724,PMC3142063.
Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP, the TrialNet and Diabetes Prevention Trial – Type 1 Study Groups
Lire la suite
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies
Diabetes Care. 2012 Jun;35(6):1213-8. doi: 10.2337/dc11- 2081. Epub 2012 Mar 23
Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL; Type 1 Diabetes TrialNet Study Group.
Lire la suite
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes
Diabetes Care. 2012 Jul;35(7):1552-5. doi: 10.2337/dc12-0011. Epub 2012 Apr 30
Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.
Lire la suite
Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth
Diabetes Care. 2012 Sep;35(9):1821-5. Epub 2012 Jun 14
Vehik K, Cuthbertson D, Boulware D, Beam CA, Rodriguez H, Legault L, Hyytinen M, Rewers MJ, Schatz DA, Krischer JP; TEDDY, TRIGR, Diabetes Prevention Trial–Type 1, and Type 1 Diabetes TrialNet Natural History Study Groups
Lire la suite
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients
Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1
Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group
Lire la suite
Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study.
Diabetes Technol Ther. 2015 Dec;17(12):867-71. doi: 10.1089/dia.2015.0133. Epub 2015 Sep 16
Bingley PJ, Rafkin LE, Matheson D, Steck AK, Yu L, Henderson C, Beam CA, Boulware DC; TrialNet Study Group.
Lire la suite
The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants
Diabetologia. 2016 Jun;59(6):1186-95. doi: 10.1007/s00125-016-3924-5. Epub 2016 Mar 19
Meah FA, DiMeglio LA, Greenbaum CJ, Blum JS, Sosenko JM, Pugliese A, Geyer S, Xu P, Evans-Molina C; Type 1 Diabetes TrialNet Study Group
Lire la suite
